Malaria in travelers. Epidemiology, disease, and prevention

Infectious Disease Clinics of North America

Volumn 12, Issue 2, 1998, Pages 267-284

  Kain, K C ^a   Keystone, J S ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; MALARIA VACCINE; MEFLOQUINE; OXYTETRACYCLINE; PRIMAQUINE; PROGUANIL; QUININE; TETRACYCLINE;

AFRICA SOUTH OF THE SAHARA; ANTIBIOTIC RESISTANCE; BED NET; BLOOD GROUP DUFFY SYSTEM; CANADA; CENTRAL AMERICA; CLIMATE; CLINICAL FEATURE; DRUG RESISTANCE; GASTROINTESTINAL DISEASE; GENETICS; HEMOLYSIS; HOST RESISTANCE; HUMAN; INDIA; INFECTION CONTROL; INFECTION RISK; INSECTICIDE RESISTANCE; MALARIA; MORBIDITY; MORTALITY; NAUSEA; NORTH AMERICA; PLASMODIUM FALCIPARUM; PREGNANCY; REVIEW; SKIN TOXICITY; SOCIOECONOMICS; SOUTH AMERICA; SOUTHEAST ASIA; TRAVEL; WORLD HEALTH ORGANIZATION;

EID: 0031830452     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70005-2     Document Type: Article

References (50)

1. S.L. Anderson J. Berman R. Kuschner Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers Ann Intern Med 123 1995 771
2. P.D. Barett P.J. Emmins P.D. Clarke Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travellers Br Med J 313 1996 525
3. E. Boudreau B. Schuster J. Sanchez Tolerability of prophylactic Lariam regimens Trop Med Parasitol 44 1993 257
4. B.J. Brabin Analysis of malaria in pregnancy in Africa Bull World Health Organ 61 1983 1005
5. C.C. Campbell Challenges facing antimalarial therapy in Africa J Infect Dis 163 1991 1207
6. Centers for Disease Control and Prevention Summary of Notifiable Diseases Morb Mortal Wkly Rep 46 1997 SS-2
7. P.H. David S.M. Handunnetti J.H. Leech Rosetting: A new cytoadherence property of malaria-infected erythrocytes Am J Trop Med Hyg 40 1989 115
8. T.M.E. Davis L.G. Dembo S.A. Kaye-Eddie Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: A double-blind, placebo-controlled trial Br J Clin Pharmacol 42 1996 415
9. de Alencar F.E.C. Cerutti C. Jr R.R. Durlacher Atovaquone and proguanil for the treatment of malaria in Brazil J Infect Dis 175 1997 1544
10. D.O. Freedman Imported malaria—here to stay Am J Med 93 1992 239
11. J.R.L. Froude L.M. Weiss H.B. Tanowitz Imported malaria in the Bronx: Review of 51 cases recorded from 1986 to 1991 Clin Infect Dis 15 1992 774
12. D.J. Fryauff J.K. Baird H. Basri Randomized placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria Lancet 346 1995 1190
13. F. Gay T. Boubacar J. Zononi Direct acridine orange fluorescence examination of blood slides compared to current techniques for malaria diagnosis Trans R Soc Trop Med Hyg 90 1996 516
14. A. Greenberg H.O. Lobel Mortality from Plasmodium falciparum malaria in travelers from the United States Ann Intern Med 113 1990 326
15. B.M. Greenwood A.K. Bradley A.M. Greenwood Mortality and morbidity from malaria among children in rural areas of The Gambia, West Africa Trans R Soc Trop Med Hyg 81 1987 478
16. H. Handszuh S.R. Waters Travel and tourism trends Dupont H.L. Steffen R. Textbook of Travel Medicine and Health 1997 BC Decker Hamilton 37
17. Health information for international travel—1996–1997 1997 Department of Health and Human Services Atlanta
18. A.V.S. Hill Malaria resistance genes: A natural selection Trans R Soc Trop Med Hyg 86 1992 225
19. A.V.S. Hill S. Bennett C.E.M. Allsopp Common West African HLA antigens are associated with protection from severe malaria Nature 352 1991 595
20. D.R. Hill R.H. Behrens D.J. Bradley The risk of malaria in travellers to Thailand Trans R Soc Trop Med Hyg 90 1996 680
21. A. Humar C. Ohrt M.A. Harington Para sight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers Am J Trop Med Hyg 56 1997 44
22. A. Humar S. Sharma D. Zoutman Fatal falciparum malaria in Canadian travellers Can Med Assoc J 156 1997 1165
23. K.C. Kain Chemotherapy of drug-resistant malaria Can J Infect Dis 7 1996 25
24. D. Kwiatkowski A.V.S. Hill I. Sambou TNF concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria Lancet 336 1990 1201
25. E.M. Lackritz H.O. Lobel J. Howell Imported Plasmodium falciparum malaria in American travelers to Africa JAMA 265 1991 383
26. Laboratory Center for Disease Control Notifiable Diseases Annual Summary—1994 Can Comm Dis Rep 22S2 1996 74
27. H.O. Lobel M. Miani T. Eng Long-term malaria prophylaxis with weekly mefloquine Lancet 341 1993 848
28. S. Looareesuwan C. Viravan H.K. Webster Clinical studies of atovaquone alone or in combination with other antimalarial drugs for the treatment of acute uncomplicated malaria in Thailand Am J Trop Med Hyg 54 1996 62
29. MacPherson D, Gamble K, Tessier D, et al: Mefloquine tolerance: Randomized double-blind placebo controlled study [abstract]. 5th Meeting of the International Society for Travel Medicine, Geneva, 1997
30. M. Molyneux R. Fox Diagnosis and treatment of malaria in Britain Br Med J 306 1993 1175
31. C.G. Nevill E.S. Some V.O. Mug'ala Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children Trop Med Intl Health 1 1996 139
32. Nosten F. ter Kuile F.O. C. Luxemburger Cardiac effects of antimalarial treatment with halofantrine Lancet 341 1993 1054
33. C. Ohrt T.L. Richie H. Widjaja Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers: A randomized, double-blind, placebo-controlled trial Ann Intern Med 126 1997 963
34. R.E. Phillips T. Solomon Cerebral malaria in children Lancet 336 1990 1355
35. P.A. Phillips-Howard D. Wood The safety of antimalarial drugs in pregnancy Drug Experience 14 1996 131
36. P. Radloff J. Phillipps M. Nkeyi Atovaquone and proguanil for Plasmodium falciparum malaria Lancet 347 1996 1511
37. TM, (atovaquone/proguanil) as a suppressive agent against Plasmodium falciparum malaria [abstract]. XIVth International Congress for Tropical Medicine and Malaria, Nagasaki, Japan, 1996
38. I.W. Sherman I. Crandall H. Smith Membrane proteins involved in the adherence of Plasmodium falciparum infected erythrocytes to the endothelium Biol Cell 74 1992 161
39. R. Steffen E. Fuchs J. Schildknecht Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa Lancet 341 1993 1299
40. J.A. Stoute M. Slaoui D.G. Heppner A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria N Engl J Med 336 1997 128
41. J.E. Svenson J.D. MacLean T.W. Gyorkos Imported malaria: Clinical presentation and examination of symptomatic travelers Arch Intern Med 155 1995 861
42. D.A. Warrell M.E. Molyneux P.F. Beales Severe and complicated malaria Trans R Soc Trop Med Hyg 84 1990 1
43. T. Weinke M. Trautmann T. Held Neuropsychiatric side effects after the use of mefloquine Am J Trop Med Hyg 45 1991 86
44. W.R. Weiss A.J. Oloo A. Johnson Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: Comparison with mefloquine, doxycycline and chloroquine plus proguanil J Infect Dis 171 1996 1569
45. N.J. White M. Ho The pathophysiology of malaria Adv Parasitol 31 1992 134
46. R.A. Winters H.W. Murray Malaria—the mime revisited: Fifteen more years of experience at a New York City teaching hospital Am J Med 93 1992 243
47. C. Wongsrichanali J. Pornsilapatips V. Namsiripongpun Acridine orange fluorescent microscopy and the detection of malaria in populations with low density parasitemia Am J Trop Med Hyg 44 1991 17
48. WHO Weekly Epidemiological Record, 71, 1996.
49. World Health Organization International Travel and Health: Vaccination requirements and health advice 1997 1997 WHO Geneva, Switzerland
50. World Health Organization A rapid dipstick antigen capture assay for the diagnosis of falciparum malaria Bull World Health Organ 74 1996 47